Welcome to LookChem.com Sign In|Join Free

CAS

  • or

29823-18-5

Post Buying Request

29823-18-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

29823-18-5 Usage

Description

Ethyl 7-bromoheptanoate is a bromoester that serves as an alkylating agent for organic compounds. It is a colorless to pale yellow liquid and is utilized in various chemical reactions and syntheses, particularly in the production of ω-chain shortened prostaglandins.

Uses

Used in Organic Synthesis:
Ethyl 7-bromoheptanoate is used as a starting material for the synthesis of benzyl 7-iodoheptanoate, which is an important intermediate in the production of various organic compounds.
Used in Pharmaceutical Research:
Ethyl 7-bromoheptanoate is used as one of the reactants in the synthesis of diethyl 7,7′-(2,5-diiodo-1,4-phenylene)bis(oxy)diheptanoate, a compound that may have potential applications in the pharmaceutical industry.
Used in the Synthesis of Carnitine-Derived Nitrones:
Ethyl 7-bromoheptanoate is employed as one of the reagents in the synthesis of CarnDOD-7C, a carnitine-derived nitrone that has potential applications in the field of neuroprotection and the treatment of neurodegenerative diseases.
Used as an Alkylating Agent:
Ethyl 7-bromoheptanoate is used as an alkylating agent in the alkylation of ethyl 3-oxoglutarate to form 2-(6-ethoxycarbonylhexyl)-3-oxoglutarate, a key step in the synthesis of various organic compounds.
Used in the Synthesis of 1-Substituted Cyclopentadienes:
Ethyl 7-bromoheptanoate is utilized in the synthesis of 1-substituted cyclopentadienes by alkylating lithium cyclopentadienide, which are important intermediates in the production of various organic compounds and materials.

Check Digit Verification of cas no

The CAS Registry Mumber 29823-18-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,8,2 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 29823-18:
(7*2)+(6*9)+(5*8)+(4*2)+(3*3)+(2*1)+(1*8)=135
135 % 10 = 5
So 29823-18-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H17BrO2/c1-2-12-9(11)7-5-3-4-6-8-10/h2-8H2,1H3

29823-18-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H28001)  Ethyl 7-bromoheptanoate, 97%   

  • 29823-18-5

  • 5ml

  • 361.0CNY

  • Detail
  • Sigma-Aldrich

  • (Y0000153)  TianeptineimpurityA  European Pharmacopoeia (EP) Reference Standard

  • 29823-18-5

  • Y0000153

  • 1,880.19CNY

  • Detail

29823-18-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 7-bromoheptanoate

1.2 Other means of identification

Product number -
Other names ethyl 7-bromo-heptanoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:29823-18-5 SDS

29823-18-5Relevant articles and documents

Process for preparing azelaic acid

-

, (2021/02/19)

A process for preparing azelaic acid is disclosed. In particular, the process for preparing azelaic acid is an ozone free process. The process for preparing azelaic acid comprises a step of decarboxylation of tetra-carboxylic acid in the presence of a organic sulfonic acid.

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS

-

Paragraph 00618; 00732, (2017/07/14)

The disclosure features amino lipids and compositions involving the same. Nanoparticle compositions include an amino lipid as well as additional lipids such as phospholipids, structural lipids, PEG lipids, or a combination thereof. Nanoparticle compositions further including therapeutic and/or prophylactic agents such as RNA are useful in the delivery of therapeutic and/or prophylactic agents to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

The value of 2JP–CO as a diagnostic parameter for the structure and thermal reactivity of carbonyl-stabilised phosphonium ylides

Aitken, R. Alan,Boubalouta, Youcef,Chang, Da,Cleghorn, Lee P.,Gray, Ian P.,Karodia, Nazira,Reid, Euan J.,Slawin, Alexandra M.Z.

, p. 6275 - 6285 (2017/09/29)

A survey of 20 carbonyl-stabilised phosphonium ylides with recently reported X-ray structures shows a strong correlation between the C[dbnd]P to C[dbnd]O torsion angle and the value of 2JP–CO, with high values being associated with an anti configuration and low with syn. Seven new X-ray structural determinations are reported, several for types of ylide not crystallographically characterised before, and these also conform to this pattern. The value of 2JP–CO is then correlated with whether or not thermal extrusion of Ph3PO occurs to give alkynes for over 200 ylides and an empirical rule developed that the extrusion never occurs for ylides where this value is > 11 Hz. This is used to rationalise the anomalous behaviour of some trioxo ylides and cyclic ylides, two of which afford cycloalkynes, isolated after rearrangement as the isomeric 1,3-dienes. The rule also holds for a family of novel highly fluorinated ylides which afford fluorinated alkynes in good yield upon flash vacuum pyrolysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 29823-18-5